NeOnc Technologies Holdings, Inc. entered into a securities purchase agreement on September 8, 2026, for a registered direct offering expected to generate approximately $15 million in gross proceeds. The company will use the net proceeds for working capital, general corporate purposes, and the redemption of its Series A Convertible Preferred Stock.
Key Details
- Offering Structure: The offering includes 2,610,715 shares of common stock, pre-funded warrants for 960,715 shares, and accompanying warrants for up to 3,571,430 shares.
- Pricing & Proceeds: The combined offering price is $4.20 per share and accompanying warrant. Gross proceeds are approximately $15 million before deducting placement agent fees (7.0%) and other expenses.
- Warrant Terms: The accompanying warrants are immediately exercisable at $4.20 per share and have a five-year term. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable until fully exercised.
- Timeline & Lock-Up: The offering is expected to close on September 10, 2026. The Company's CEO and Chief Medical Officer have entered into 90-day lock-up agreements.